Over the past few decades, the neuropathological diagnostic criteria for AD have focused on the presence of extracellular Aβ amyloid deposits known as neuritic plaques and intracellular tau protein hyperphosphorylation referred to as neurofibrillary tangles (NFTs) (5). The gene discussed is MAPT; the disease is Alzheimer disease.